Rheumatic Heart Disease: Progress and Challenges in India

Indian Journal of Pediatrics

Volumn 80, Issue , 2013, Pages 77-86

  Shah, Bela ^a   Sharma, Meenakshi ^a   Kumar, Rajesh ^b   Brahmadathan, K N ^c   Abraham, Vinod Joseph ^c   Tandon, Rajan ^d  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d SITARAM BHARTIA INSTITUTE OF SCIENCE AND RESEARCH   (India)

Author keywords

Group A beta hemolytic streptococcus (GAS); Prevalence; Primary prevention; Rheumatic fever (RF); Rheumatic heart disease (RHD); Secondary prevention

Indexed keywords

ANTIINFECTIVE AGENT; BENZATHINE PENICILLIN;

CHILD; COMPLICATION; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ETHNOLOGY; HUMAN; INDIA; LONG TERM CARE; NEGLECTED DISEASES; PHARYNGITIS; PRACTICE GUIDELINE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CHILD; DEVELOPING COUNTRIES; EARLY DIAGNOSIS; HUMANS; INDIA; LONG-TERM CARE; NEGLECTED DISEASES; PENICILLIN G BENZATHINE; PHARYNGITIS; PRACTICE GUIDELINES AS TOPIC; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84877775400     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-012-0853-2     Document Type: Review

References (71)

1. Lancefield RC. The antigenic complex of Streptococcus haemolyticus. I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus. J Exp Med. 1928;47:91–103.
2. Facklam RF, Martin DR, Lovgren M, et al. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis. 2002;34:28–38.
3. Sharma M, Shah B, Dhaliwal RS. Heterogeneity of community based pediatric GAS isolates from India: Challenges to the multivalent vaccine approach. International Congress Series. 2006;1289:49–53.
4. Dey N, Mcmillan DJ, Yarwood PJ, et al. High diversity of group A streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis. 2005;40:46–51.
5. Lloyd CA, Jacob SE, Menon T. Pharyngeal carriage of group A streptococci in school children in Chennai. Indian J Med Res. 2006;124:195–8.
6. Kumar R, Vohra H, Chakraborty A, et al. Epidemiology of group A streptococcal pharyngitis & impetigo: a cross-sectional & follow up study in a rural community of northern India. Indian J Med Res. 2009;130:765–71.
7. Sagar V, Bakshi DK, Nandi S, Ganguly NK, Kumar R, Chakraborti A. Molecular heterogeneity among north Indian isolates of Group A streptococcus. Lett Appl Microbiol. 2004;39:84–8.
8. Menon T, Lloyd C, Malathy B, Sakota V, Jackson D, Beall B. 12.emm type diversity of beta - a hemolytic streptococci recovered in Chennai, India. J Med Microbiol. 2008;57:540–2.
9. Dhanda V, Kumar R, Thakur JS, Chakraborti A. emm type distribution pattern of group A streptococcus in north India: need for a new preventive approach. Indian J Med Res. 2010;132:741–4.
10. Smith TD, Wilkinson V, Kaplan EL. Group A streptococcus-associated upper respiratory tract infections in a day-care center. Pediatrics. 1989;83:380–4.
11. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.
12. Rammelkamp CH, Denny FW, Wannamaker LW. Studies on the epidemiology of rheumatic fever in the armed Services. In: Thomas L, ed. Rheumatic fever. Minneapolis: University of Minnesota Press; 1952. pp. 72–89.
13. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population - Factors related to the attack rate of rheumatic fever. N Engl J Med. 1961;265:559–66.
14. Spagnuolo M, Pasternak B, Taranta A. Risk of rheumatic-fever recurrences after streptococcal infections. Prospective study of clinical and social factors. N Engl J Med. 1971;285:641–7.
15. Dajani AS. Current status of nonsuppurative complications of group A streptococci. Pediatr Infect Dis J. 1991;10:S25–27.
16. Rajkumar S, Krishnamurthy R. Isolation of group A β hemolytic streptococci in the tonsillopharynx of school children in Madras city and correlation with their clinical features. Jpn J Infect Dis. 2001;54:137–9.
17. Menon T, Shanmugasundaram S, Kumar MP, Kumar CP. Group a streptococcal infections of the pharynx in a rural population in south India. Indian J Med Res. 2004;119:171–3.
18. Smeesters PR, Vergison A, Campos D, de Aguiar E, Miendje Deyi VY, Van Melderen L. Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape. PLoS ONE. 2006;1:e10.
19. McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis. 2006;43:683–9.
20. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet. 1996;347:1271–2.
21. Parks T, Smeesters PR, Steer AC. Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis. 2012;25:145–53.
22. Bland EF, Jones TD. Rheumatic fever and rheumatic heart disease - A twenty year report on 1000 patients followed since childhood. Circulation. 1951;4:836–43.
23. Padmawati S. Rheumatic fever and rheumatic disease in development countries. Bull World Health Organization. 1978;56:543–50.
24. Roy SB, Bhatia ML, Lazaro EJ, Ramalingaswami V. Juvenile mitral stenosis in India. Lancet. 1963;2:1193–5.
25. Cherian G, Vytilingam KI, Sukumar IP, Gopinath N. Mitral valvotomy in young patients. Br Heart J. 1964;26:157–66.
26. Marijon E, Iung B, Mocumbi AO, et al. What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure? Arch Cardiovasc Dis. 2008;101:611–7.
27. Mardini MK. Rheumatic fever and its cardiac manifestations in children: an update. KFSH Med. 1981;1:131–9.
28. Andy JJ, Soomro RM. The changing incidence of juvenile mitral stenosis and natural history of rheumatic mitral valvulitis inAl Baha, Saudi Arabia. Ann Trop Paediatr. 2001;21:105–9.
29. Altamimi S, Khalil A, Khalaiwi KA, Milner R, Pusic MV, Al Othman MA. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev. 2009;1:CD004872.
30. Carapetis JR. Rheumatic heart disease in Asia. Circulation. 2008;118:2748–53.
31. Grover A, Dhawan A, Iyengar SD, Anand IS, Wahi PL, Ganguly NK. Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull World Health Organ. 1993;71:59–66.
32. Kumar P, Garhwal S, Chaudhary V. Rheumatic heart disease: a school survey in a rural area of Rajasthan. Indian Heart J. 1992;44:245–6.
33. Vashistha VM, Kalra A, Kalra K, Jain VK. Prevalence of rheumatic heart disease in school children. Indian Pediatr. 1993;30:53–6.
34. Patel DC, Patel NI, Patel JD, Patel SD. Rheumatic fever and rheumatic heart disease in school children of Anand. J Assoc Physicians India. 1986;34:837–9.
35. Avasthi G, Singh D, Singh C, Aggarwal SP, Bidwai PS, Avasthi R. Prevalence survey of rheumatic fever (RF) and rheumatic heart disease (RHD) in urban & rural school children in Ludhiana. Indian Heart J. 1987;39:26–8.
36. Agarwal AK, Yunus M, Ahmad J, Khan A. Rheumatic heart disease in India. J R Soc Health. 1995;115:303–4. 309.
37. Thakur JS, Negi PC, Ahluwalia SK, Vaidya NK. Epidemiological survey of rheumatic heart disease among school children in the Shimla Hills of northern India: prevalence and risk factors. J Epidemiol Community Health. 1996;50:62–7.
38. Thakur JS, Negi PC, Ahluwalia SK, Sharma R, Bhardwaj R. Congenital heart disease among school children in Shimla hills. Indian Heart J. 1995;47:232–5.
39. Gupta I, Gupta ML, Parihar A, Gupta CD. Epidemiology of rheumatic and congenital heart diseases in school children. J Indian Med Assoc. 1992;90:57–9.
40. Jose VJ, Gomathi M. Declining prevalence of rheumatic heart disease in rural schoolchildren in India: 2001–2002. Indian Heart J. 2003;55:158–60.
41. Periwal KL, Gupta BK, Panwar RB, Khatri PC, Raja S, Gupta R. Prevalence of rheumatic heart disease in school children in Bikaner: an echocardiographic study. J Assoc Physicians India. 2006;54:279–82.
42. Community control of rheumatic fever and rheumatic heart disease. Report of ICMR task force study. New Delhi: Indian Council of Medical Research; 1994.
43. Jai Vigyan Mission mode project on community control of RHD. Non-communicable diseases. Indian Council Med Res Annu Rep 2007–08; pp 63–4.
44. rd March 2012)
45. Carapetis JR, Hardy M, Fakakovikaetau T, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med. 2008;5:411–7.
46. Jaffe WM, Roche AH, Coverdale HA, McAlister HF, Ormiston JA, Greene ER. Clinical evaluation versus Doppler echocardiography in the quantitative assessment of valvular heart disease. Circulation. 1988;78:267–75.
47. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470–6.
48. Anabwani GM, Bonhoeffer P. Prevalence of heart disease in school children in rural Kenya using colour-flow echocardiography. East Afr Med J. 1996;73:215–7.
49. Paar JA, Berrios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010;105:1809–14.
50. Bhaya M, Panwar S, Beniwal R, Panwar RB. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography. 2010;27:448–53.
51. Saxena A, Ramakrishnan S, Roy A, et al. Global burden of cardiovascular disease Prevalence and outcome of subclinical rheumatic heart disease in India: The RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart. 2011;97:2018–22.
52. Marijon E, Celermajer DS, Tafflet M, et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009;120:663–8.
53. Reményi Bo, Wilson N, Steer A. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease— an evidence-based guideline. Nat Rev Cardiol. 2012;9:297–309.
54. Mirabel M, Celermajer DS, Ferreira B et al. Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. Eur Heart J Cardiovasc Imaging. 2012. http://ehjcimaging.oxfordjournals.org/content/early/2012/04/19/ehjci.jes077.abstract. (Accessed 5th June 2012)
55. Bhaya M, Beniwal R, Panwar S, Panwar RB. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography. 2011;28:929–33.
56. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2009;119:1541–51.
57. Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of Pediatrics, Saxena A, Kumar RK, Gera RP, Radhakrishnan S, Mishra S, Ahmed Z. Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease. Indian Pediatr. 2008;45:565–73.
58. Bisno AL, Gerber MA, Gwaltney Jr JM. Kaplan EL, Schwartz RH. Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35:113–25.
59. Jones TD. The diagnosis of rheumatic fever. JAMA. 1944;126:481–4.
60. Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Circulation. 1993;87:302–7.
61. Ferrieri P, for the Jones Criteria Working Group. AHA scientific statement proceedings of the Jones Criteria workshop. Circulation. 2002;106:2521–3.
62. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Diagnosis and management of Acute Rheumatic fever and Rheumatic heart disease in Australia – An evidence based review. 2006. http://www.racgp.org.au/Content/NavigationMenu/ClinicalResources/RACGPGuidelines/DiagnosisandmanagementofacuterheumaticfeverandrheumaticheartdiseaseinAustralia/NHFA-CSANZ_ARF_RHD_2006.pdf Accessed on 2nd March 2012.
63. Marijon E, Ou P, Celermajer DS, et al. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ. 2008;86:84.
64. Marijon E, Celermajer DS, Jouven X. Management of patients with subclinical rheumatic heart disease. Int J Cardiol. 2009;134:295–6.
65. Horn DL, Zabriskie JB, Austrian R, et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis. 1998;26:1341–5.
66. Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilário MO. Resource utilization and cost of rheumatic fever. The Journal of Rheumatology. 2001;28:1394–7.
67. Soudarssanane MB, Karthigeyan M, Mahalakshmy T, et al. Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option. Indian J Pediatr. 2007;74:567–70.
68. Karthikeyan G, Mayosi BM. Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation. 2009;120:709–13.
69. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379:953–64.
70. Steer AC, Batzloff MR, Mulholland K, Carapetis JR. Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis. 2009;22:544–52.
71. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991;337:1308–10.